News|Articles|November 15, 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Author(s)Phenomenex, Inc.
Fact checked by: Phenomenex, Inc.
Learn the latest techniques for improved chromatographic performance and throughput of AAV analysis.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Charles River Incubator Cohort to Accelerate CGT Development
3
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
4
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
5
